Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Toxocara Seroprevalence in the US & Risk Factors

Clin Infect Dis; ePub 2017 Sep 4; Liu, et al

While Toxocara seroprevalence estimates in the US were lower in 2011-2014 than from a previous study from 1988-1994, seropositivity risk factors remained unchanged, a recent study found. The study used a multiplex bead based assay with purified Toxocara canis antigen to estimate Toxocara antibody seroprevalence in a serum of 13,509 persons aged ≥6 years from the National Health and Nutrition Examination Survey (NHANES), 2011-2014, and identified seropositivity risk factors. Researchers found:

  • The age standardized estimate of Toxocara seroprevalence was 5.0%; this was lower than previously reported.
  • Risk factors for seropositivity from multiple logistic regression were older age, non-Hispanic black race/Hispanic origin vs non-Hispanic white, male sex, living below the poverty level, households with ≥0.5 persons per room, less than college education, and birth outside the US.


Liu EW, Chastain HM, Shin SH, et al. Seroprevalence of antibodies to Toxocara species in the United States and associated risk factors, 2011- 2014. [Published online ahead of print September 4, 2017]. Clin Infect Dis. doi:10.1093/cid/cix784.

This Week's Must Reads

Female HIV-1 Risk in Pregnancy and Postpartum, J Infect Dis; ePub 2018 Mar 5; Thomson, et al

Disparities in Lifetime Risk of Chlamydia Diagnosis, Clin Infect Dis; ePub 2018 Mar 5; Chambers, et al

Effects of PrEP for HIV Prevention in MSM, Clin Infect Dis; ePub 2018 Mar 2; Traeger, et al

Prevention of Recurrent CDI in High-Risk Patients, Clin Infect Dis; ePub 2018 Mar 10; Gerding, et al

Impact of Implementing ASPs in Small Hospitals, Clin Infect Dis; ePub 2018 Feb 23; Stenehjem, et al

Must Reads in Mycoses

Toxocara Seroprevalence in the US & Risk Factors, Clin Infect Dis; ePub 2017 Sep 4; Liu, et al

Mucormycosis-Related Hospitalization Trends in US, Open Forum Infect Dis; ePub 2017 Jan 13; Vallabhaneni, et al

Mucormycosis-Related Hospitalizations in the US, BMC Infect Dis; ePub 2016 Dec 1; Kontoyiannis, et al

Practice Guidelines for Treatment of Coccidioidomycosis , Clin Infect Dis; ePub 2016 Jul 27; Galgiani, et al

Infection in TNFI Therapy, Is there an association?